HCC 112 (V28)
Immune Thrombocytopenia and Specified Coagulation Defects and Hemorrhagic Conditions
21 ICD-10-CM codes map to this category in the CMS-HCC V28 risk adjustment model for payment year 2027. All 115 HCCs
Overridden by: HCC 111 (Hemophilia, Male). If the patient also has one of these, only the higher HCC counts.
| D68.00 | Von Willebrand disease, unspecified |
| D68.01 | Von Willebrand disease, type 1 |
| D68.020 | Von Willebrand disease, type 2A |
| D68.021 | Von Willebrand disease, type 2B |
| D68.022 | Von Willebrand disease, type 2M |
| D68.023 | Von Willebrand disease, type 2N |
| D68.029 | Von Willebrand disease, type 2, unspecified |
| D68.03 | Von Willebrand disease, type 3 |
| D68.04 | Acquired von Willebrand disease |
| D68.09 | Other von Willebrand disease |
| D68.1 | Hereditary factor XI deficiency |
| D68.2 | Hereditary deficiency of other clotting factors |
| D68.311 | Acquired hemophilia |
| D69.1 | Qualitative platelet defects |
| D69.3 | Immune thrombocytopenic purpura |
| D69.41 | Evans syndrome |
| D69.42 | Congenital and hereditary thrombocytopenia purpura |
| D69.49 | Other primary thrombocytopenia |
| D75.84 | Other platelet-activating anti-PF4 disorders |
| M31.10 | Thrombotic microangiopathy, unspecified |
| M31.19 | Other thrombotic microangiopathy |